IP
Intellectus Partners Portfolio holdings
AUM
$578M
Turnover
15.36%
1-Year Est. Return
49.48%
This Fund
S&P 500
This Quarter
Est. Return
+7.3%
1 Year Est. Return
+49.48%
3 Year Est. Return
+157.34%
5 Year Est. Return
+153.66%
10 Year Est. Return
–
AUM
$443M
AUM Growth
+$79.4M
(+22%)
Cap. Flow
+$58.1M
Cap. Flow
% of AUM
13.09%
Top 10 Holdings %
Top 10 Hldgs %
28.62%
Holding
280
New
38
Increased
121
Reduced
93
Closed
8
Avg Time Held Equity + Options
1.8
years
Top 10 Avg Time Held Equity + Options
1.9
years
Top 20 Avg Time Held Equity + Options
2
years
Avg Time Held Equity only
1.9
years
Top 10 Avg Time Held Equity only
1.9
years
Top 20 Avg Time Held Equity only
2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbCellera Biologics
ABCL
|
+$33.3M |
| 2 |
Lam Research
LRCX
|
+$3.84M |
| 3 |
Strata Critical Medical Inc
SRTA
|
+$1.67M |
| 4 |
iShares Silver Trust
SLV
|
+$1.54M |
| 5 |
Affimed
AFMD
|
+$1.42M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intellia Therapeutics
NTLA
|
+$1.79M |
| 2 |
Virgin Galactic
SPCE
|
+$1.1M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$947K |
| 4 |
Blackstone
BX
|
+$874K |
| 5 |
IACA
ION Acquisition Corp 1 Ltd.
IACA
|
+$819K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 19.51% |
| 2 | Healthcare | 19.33% |
| 3 | Technology | 19.31% |
| 4 | Consumer Discretionary | 12.84% |
| 5 | Communication Services | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
226
AT&T
T
$158B
| $323K | 0.07% |
14,851
+1,189
| +9% | +$27K |
2020 Q4
2 quarters
|
|
227
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.43B
| $316K | 0.07% |
6,092
+700
| +13% | +$36.3K |
2019 Q1
9 quarters
|
|
228
Clover Health Investments
CLOV
$2.55B
| $311K | 0.07% |
23,330
-18,015
| -44% | -$177K |
2021 Q1
1 quarter
|
|
229
Nano Dimension
NNDM
$598M
| $311K | 0.07% |
37,693
-1,220
| -3% | -$9.03K |
2020 Q1
5 quarters
|
|
230
iShares Core MSCI Emerging Markets ETF
IEMG
$155B
| $297K | 0.07% |
4,432
-1,428
| -24% | -$94.1K |
2019 Q1
9 quarters
|
|
|
MYC
231
DELISTED
Blackrock Muni Yield California Fund, Inc.
MYC
| $296K | 0.07% |
19,163
+40
| +0.2% | +$609 |
2019 Q1
9 quarters
|
|
232
DocuSign
DOCU
$14B
| $294K | 0.07% |
1,050
| – | – |
2020 Q4
2 quarters
|
|
|
KSU
233
DELISTED
Kansas City Southern
KSU
| $294K | 0.07% |
1,036
-1,469
| -59% | -$424K |
2016 Q4
18 quarters
|
|
234
Vision Marine Technologies
VMAR
$3.64M
| – | – |
0
| – | – |
2020 Q4
2 quarters
|
|
|
AYX
235
DELISTED
Alteryx Inc
AYX
| $290K | 0.07% |
3,375
+200
| +6% | +$16.4K |
2020 Q4
2 quarters
|
|
236
Crescent Biopharma
CBIO
$471M
| $285K | 0.06% |
1,230
+420
| +52% | +$107K |
2020 Q4
2 quarters
|
|
237
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.1B
| $285K | 0.06% |
1,205
+1
| +0.1% | +$224 |
2021 Q1
1 quarter
|
|
238
Quest Diagnostics
DGX
$25.7B
| $278K | 0.06% |
2,108
-709
| -25% | -$92.8K |
2020 Q1
5 quarters
|
|
239
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.55B
| $270K | 0.06% |
2,432
-470
| -16% | -$51.8K |
2019 Q1
9 quarters
|
|
240
Vanguard Energy ETF
VDE
$11.3B
| $267K | 0.06% |
3,521
-189
| -5% | -$13.7K |
2021 Q1
1 quarter
|
|
241
Invesco National AMT-Free Municipal Bond ETF
PZA
$4.03B
| $266K | 0.06% |
9,754
| – | – |
2020 Q3
3 quarters
|
|
|
POL.WS
242
DELISTED
Polished.com Inc. Warrants to Purchase Common Stock
POL.WS
| $263K | 0.06% |
+123,030
| New | +$180K |
2021 Q2
0 quarters
|
|
243
DELISTED
BlackRock MuniYield Fund
MYD
| $258K | 0.06% |
17,000
| – | – |
2019 Q1
9 quarters
|
|
244
Direxion Daily S&P 500 Bear 1X ETF
SPDN
$294M
| $253K | 0.06% |
16,000
-2,000
| -11% | -$32.6K |
2020 Q2
4 quarters
|
|
245
Bank of New York Mellon
BNY
$92.6B
| $250K | 0.06% |
4,885
| – | – |
2021 Q1
1 quarter
|
|
246
Principal Real Estate Income Fund
PGZ
$58.6M
| $246K | 0.06% |
16,189
+104
| +0.6% | +$1.56K |
2016 Q4
18 quarters
|
|
247
Jacobs Solutions
J
$16.4B
| $241K | 0.05% |
2,185
+5
| +0.2% | +$565 |
2021 Q1
1 quarter
|
|
248
Valero Energy
VLO
$132B
| $240K | 0.05% |
3,068
| – | – |
2021 Q1
1 quarter
|
|
249
MillerKnoll
MLKN
$1.45B
| $238K | 0.05% |
+5,037
| New | +$228K |
2021 Q2
0 quarters
|
|
|
FLZH
250
DELISTED
FLASH SPORTS & MEDIA HLDG
FLZH
| $235K | 0.05% |
1,024
+364
| +55% | +$80K |
2021 Q1
1 quarter
|
|
Similar funds
AFGAS
RWM
AHL
CTAF
HIM
SSP
CA
PWM
Intellectus Partners's Q2 2021 Portfolio in Review
As of Q2 2021, Intellectus Partners held 280 positions worth $443M, up 22% from $364M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Intellectus Partners deployed $58.1M of net new capital in Q2 2021, opening 38 new positions and adding to 121 existing holdings. Its largest new stake was AbCellera Biologics: 1,206,979 shares worth $26.6M.
By sector, the portfolio is most concentrated in Miscellaneous at 20% of assets, down from 22% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Intellia Therapeutics, an estimated $1.79M trimmed.
- Intellectus Partners's largest Q2 2021 buy was AbCellera Biologics: 1,206,979 shares worth $26.6M.
- Intellectus Partners added most to iShares Silver Trust in Q2 2021, an estimated $1.54M increase.
- Intellectus Partners's biggest Q2 2021 reduction was Intellia Therapeutics, cutting an estimated $1.79M.
- Intellectus Partners fully exited Virgin Galactic in Q2 2021, selling an estimated $1.1M.
- Intellectus Partners's ten largest holdings make up 29% of its $443M portfolio in Q2 2021.
- Intellectus Partners opened 38 new positions and closed 8 in Q2 2021.
- Intellectus Partners's portfolio value rose 22% quarter-over-quarter to $443M.
Based on Intellectus Partners's 13F filing for Q2 2021, filed 13 Aug 2021.